PTPBR7 binding proteins in myelinating neurons of the mouse brain

International Journal of Biological Sciences

Volumn 7, Issue 7, 2011, Pages 978-991

  Chesini, Irene M ^a   Debyser, Griet ^b   Croes, Huib ^a   ten Dam, Gerdy B ^a   Devreese, Bart ^b   Stoker, Andrew W ^c   Hendriks, Wiljan J A J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cerebellum; Extracellular domain; Ligand protein; Mass spectrometry; Protein tyrosine phosphatase; PTPRR; RAP in situ

Indexed keywords

MUS;

EID: 80052772977     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.7.978     Document Type: Article

References (43)

1. Dityatev A, Schachner M, Sonderegger P. The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat Rev Neurosci. 2010; 11: 735-746.
2. Togashi H, Sakisaka T, Takai Y. Cell adhesion molecules in the central nervous system. Cell Adh Migr. 2009; 3: 29-35.
3. Hendriks WJ, Elson A, Harroch S, Stoker AW. Protein tyrosine phosphatases: functional inferences from mouse models and human diseases. Febs J. 2008; 275: 816-830.
4. Johnson KG, Van Vactor D. Receptor protein tyrosine phos-phatases in nervous system development. Physiol Rev. 2003; 83: 1-24.
5. Stoker AW. Receptor tyrosine phosphatases in axon growth and guidance. Curr Opin Neurobiol. 2001; 11: 95-102.
6. den Hertog J, Ostman A, Bohmer FD. Protein tyrosine phos-phatases: regulatory mechanisms. Febs J. 2008; 275: 831-847.
7. Johnson KG, Tenney AP, Ghose A, Duckworth AM, Higashi ME, Parfitt K, Marcu O, Heslip TR, Marsh JL, Schwarz TL, Flanagan JG, Van Vactor D. The HSPGs Syndecan and Dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic development. Neuron. 2006; 49: 517-531.
8. Kwon SK, Woo J, Kim SY, Kim H, Kim E. Trans-synaptic adhe-sions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excit-atory synapse formation. J Biol Chem. 2010;285: 13966-13978.
9. Shen Y, Tenney AP, Busch SA, Horn KP, Cuascut FX, Liu K, He Z, Silver J, Flanagan JG. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Sci-ence. 2009; 326: 592-596.
10. Krasnoperov V, Bittner MA, Mo W, Buryanovsky L, Neubert TA, Holz RW, Ichtchenko K, Petrenko AG. Protein-tyrosine phosphatase-sigma is a novel member of the functional family of alpha-latrotoxin receptors. J Biol Chem. 2002; 277: 35887-35895.
11. Aricescu AR, McKinnell IW, Halfter W, Stoker AW. Heparan sulfate proteoglycans are ligands for receptor protein tyrosine phosphatase sigma. Mol Cell Biol. 2002; 22: 1881-1892.
12. Alete DE, Weeks ME, Hovanession AG, Hawadle M, Stoker AW. Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phospha-tase-sigma. Febs J. 2006; 273: 4668-4681.
13. Fry EJ, Chagnon MJ, Lopez-Vales R, Tremblay ML, David S. Corticospinal tract regeneration after spinal cord injury in re-ceptor protein tyrosine phosphatase sigma deficient mice. Glia. 2010; 58: 423-433.
14. O'Grady P, Thai TC, Saito H. The laminin-nidogen complex is a ligand for a specific splice isoform of the transmembrane pro-tein tyrosine phosphatase LAR. J Cell Biol. 1998; 141: 1675-1684.
15. Bouyain S, Watkins DJ. The protein tyrosine phosphatases PTPRZ and PTPRG bind to distinct members of the contactin family of neural recognition molecules. Proc Natl Acad Sci U S A. 2010; 107: 2443-2448.
16. Fukada M, Fujikawa A, Chow JP, Ikematsu S, Sakuma S, Noda M. Protein tyrosine phosphatase receptor type Z is inactivated by ligand-induced oligomerization. FEBS Lett. 2006; 580: 4051-4056.
17. Noordman YE, Augustus ED, Schepens JT, Chirivi RG, Rios P, Pulido R, Hendriks WJ. Multimerisation of receptor-type pro-tein tyrosine phosphatases PTPBR7 and PTP-SL attenuates en-zymatic activity. Biochim Biophys Acta. 2008; 1783: 275-286.
18. van den Maagdenberg AM, Bachner D, Schepens JT, Peters W, Fransen JA, Wieringa B, Hendriks WJ. The mouse Ptprr gene encodes two protein tyrosine phosphatases, PTP-SL and PTPBR7, that display distinct patterns of expression during neural development. Eur J Neurosci. 1999; 11: 3832-3844.
19. Chirivi RG, Noordman YE, Van der Zee CE, Hendriks WJ. Altered MAP kinase phosphorylation and impaired motor co-ordination in PTPRR deficient mice. J Neurochem. 2007; 101: 829-840.
20. Hendriks WJ, Dilaver G, Noordman YE, Kremer B, Fransen JA. PTPRR Protein Tyrosine Phosphatase Isoforms and Locomotion of Vesicles and Mice. Cerebellum. 2009; 8: 80-88.
21. Flanagan JG, Leder P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell. 1990; 63: 185-194.
22. Flanagan JG, Cheng H-J, Feldheim DA, Hattori M, Lu Q, Vanderhaeghen P. Alkaline phosphatase fusions of ligands or receptors as in situ probes for staining of cells, tissues, and embryos. Methods Enzymol. 2000; 327: 19-35.
23. Aricescu AR, Lu W, Jones EY. A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr D Biol Crystallogr. 2006; 62: 1243-1250.
24. Aricescu AR, Siebold C, Choudhuri K, Chang VT, Lu W, Davis SJ, van der Merwe PA, Jones EY. Structure of a Tyrosine Phos-phatase Adhesive Interaction Reveals a Spacer-Clamp Mecha-nism. Science. 2007; 317: 1217-1220.
25. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH. Generation and application of type-specific an-ti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kid-ney. J Biol Chem. 1998; 273: 12960-12966.
26. Dilaver G, van de Vorstenbosch R, Tarrega C, Rios P, Pulido R, van Aerde K, Fransen J, Hendriks W. Proteolytic processing of the receptor-type protein tyrosine phosphatase PTPBR7. Febs J. 2007; 274: 96-108.
27. Kreis TE. Microinjected antibodies against the cytoplasmic domain of vesicular stomatitis virus glycoprotein block its transport to the cell surface. EMBO J. 1986; 5: 931-941.
28. Smetsers TFCM, van de Westerlo EMA, ten Dam GB, Overes IM, Schalkwijk J, van Muijen GNP, van Kuppevelt TH. Human Single-Chain Antibodies Reactive with Native Chondroitin Sulfate Detect Chondroitin Sulfate Alterations in Melanoma and Psoriasis. J Invest Dermatol. 2004 Mar;122(3):707-16.
29. ten Dam GB, van de Westerlo EM, Purushothaman A, Stan RV, Bulten J, Sweep FC, Massuger LF, Sugahara K, van Kuppevelt TH. Antibody GD3G7 selected against embryonic glycosa-minoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endo-thelial growth factor binding. Am J Pathol. 2007; 171: 1324-1333.
30. Stoker A. Methods for identifying extracellular ligands of RPTPs. Methods. 2005; 35: 80-89.
31. Sajnani-Perez G, Chilton JK, Aricescu AR, Haj F, Stoker AW. Isoform-specific binding of the tyrosine phosphatase PTPsigma to a ligand in developing muscle. Mol Cell Neurosci. 2003; 22: 37-48.
32. Abramoff MD, Magelhaes PJ, Ram SJ. Image Processing with ImageJ. Biophotonics International. 2004; 11: 36-42.
33. Franklin RJM, ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci. 2008 Nov;9(11):839-55.
34. Lee S, Faux C, Nixon J, Alete D, Chilton J, Hawadle M, Stoker AW. Dimerization of Protein Tyrosine Phosphatase {sigma} Governs both Ligand Binding and Isoform Specificity. Mol Cell Biol. 2007; 27: 1795-1808.
35. Kwok JC, Afshari F, Garcia-Alias G, Fawcett JW. Proteoglycans in the central nervous system: plasticity, regeneration and their stimulation with chondroitinase ABC. Restor Neurol Neurosci. 2008; 26: 131-145.
36. Harroch S, Furtado GC, Brueck W, Rosenbluth J, Lafaille J, Chao M, Buxbaum JD, Schlessinger J. A critical role for the protein tyrosine phosphatase receptor type Z in functional re-covery from demyelinating lesions. Nat Genet. 2002; 32: 411-414.
37. Hashimoto T, Maekawa S, Miyata S. IgLON cell adhesion mol-ecules regulate synaptogenesis in hippocampal neurons. Cell Biochem Funct. 2009; 27: 496-498.
38. Chen S, Gil O, Ren YQ, Zanazzi G, Salzer JL, Hillman DE. Neurotrimin expression during cerebellar development sug-gests roles in axon fasciculation and synaptogenesis. J Neuro-cytol. 2001; 30: 927-937.
39. Wayman GA, Lee YS, Tokumitsu H, Silva AJ, Soderling TR. Calmodulin-kinases: modulators of neuronal development and plasticity. Neuron. 2008; 59: 914-931.
40. Butler LS, Silva AJ, Abeliovich A, Watanabe Y, Tonegawa S, McNamara JO. Limbic epilepsy in transgenic mice carrying a Ca2+/calmodulin-dependent kinase II alpha-subunit mutation. Proc Natl Acad Sci U S A. 1995; 92: 6852-6855.
41. Greif GJ, Sodickson DL, Bean BP, Neer EJ, Mende U. Altered regulation of potassium and calcium channels by GABA(B) and adenosine receptors in hippocampal neurons from mice lacking Galpha(o). J Neurophysiol. 2000; 83: 1010-1018.
42. Jiang M, Gold MS, Boulay G, Spicher K, Peyton M, Brabet P, Srinivasan Y, Rudolph U, Ellison G, Birnbaumer L. Multiple neurological abnormalities in mice deficient in the G protein Go. Proc Natl Acad Sci U S A. 1998; 95: 3269-3274.
43. Valenzuela D, Han X, Mende U, Fankhauser C, Mashimo H, Huang P, Pfeffer J, Neer EJ, Fishman MC. G alpha(o) is neces-sary for muscarinic regulation of Ca2+ channels in mouse heart. Proc Natl Acad Sci U S A. 1997; 94: 1727-1732.